ClinicalTrials.gov
public full text
Public Domain
Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tolvaptan Extension Study in Participants With ADPKD#876203
- HALT Progression of Polycystic Kidney Disease Study A#125976
- Transformative Research in Diabetic Nephropathy#910539
- Challenges in Classification of PKD1 Missense Variation in Autosomal Dominant Polycystic Kidney Disease#619221
- Burden of Chronic Kidney Disease in Asia From 1990 to 2023: A Global Burden of Disease Study 2023.#437124
Record · ID 838581
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive